Cargando…
Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia
B-cell chronic lymphocytic leukaemia (CLL) is associated with immunosuppression and patients are at increased clinical risk following SARS-CoV-2 infection. Covid-19 vaccines offer the potential for protection against severe infection but relatively little is known regarding the profile of the antibo...
Autores principales: | Parry, H., McIlroy, G., Bruton, R., Ali, M., Stephens, C., Damery, S., Otter, A., McSkeane, T., Rolfe, H., Faustini, S., Wall, N., Hillmen, P., Pratt, G., Paneesha, S., Zuo, J., Richter, A., Moss, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323747/ https://www.ncbi.nlm.nih.gov/pubmed/34330895 http://dx.doi.org/10.1038/s41408-021-00528-x |
Ejemplares similares
-
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
por: Parry, Helen, et al.
Publicado: (2022) -
NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma
por: Parry, Helen M., et al.
Publicado: (2016) -
Long-Term Ibrutinib Therapy Reverses CD8(+) T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia
por: Parry, Helen M., et al.
Publicado: (2019) -
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
por: Parry, Helen, et al.
Publicado: (2022) -
Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia
por: Paneesha, S., et al.
Publicado: (2020)